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Formulation and physicochemical characterization of solid lipid
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Introduction: Multiple Sclerosis is an autoimmnne disease in which T-cells attack asain.:
neuron's Myelin and the efficiency of nervous system is decreased over time. One of the .',r:.
tnedicines for MS is Dirnethyl Fumarate (DMF) that treats relapsing-remitting MS. DMF has
several adverse effects like abdominal pain, diarrhea, nausea and flushing. Also, D\fF
passing through Blood-Brain Barrier is difficult and has low permanency in nervous svstenr
One of the new drug-delivery systems is solid lipid nanoparticles that can compensate th;
adverse effects and the passing problems of DMF.
Methods: In this study, first, the hrr* of DMF was determined for using in the next stage s
Then, several forrnulations were prepared with various percentage of components. Hig:-
shear homogenization and ultrasound method were used to prepare the formulations. In t}. .
stage, the solid lipid was Witepsol-H35 and the surfactants were Tween'e 80, Tween& 20 a:.:
Span@ 80. Then, the sizes of nanopafticles were anal5,zed and a formulation rvith 56.1 r::
average size was selected for the next steps. Also, the formation of nanopafiicles ..''
confirmed by optical microscope photography. At last, physicocherrical propefiies of . .
best formulation rvas studied.
Results: The valr.re of tr-u* was212.9 nm. Encapsulation efficacy of loaded DMF rvas 5-i -
formulation diffusion waslo/o after 60 min while diffusion for solute fbrm w-as l9oti.lt n,:: l
that forrnulation is controlled-release. The amount of drug that was released after l-,- : -
was about 160/ob.ut for solute fonn, it was22Yo.lt means that formulation is a sLl::-::-:--
release. Furthermore, the physical stability of the formulation was investlgate; :
formulation was stored in refrigerator, rooln and oven temperature rvithout anr ;hr::=,
color and consistency aft-er 4 month.
Conclusion: Based on this project's results, the selected formr.rlation sl',.-i,.. :, : :
characteristics. Therefore, it is recommended to investigate the in t'i/t'o and li; '. :'. ;r : 
-
the SLN formulation in comparison to DMF powder.
ilI
IV




irt Jt dL;o 
=lil*e etc.ti 9 ..Ji1l, nt& clSiilogjt r.rls c.tiiib
tPl o1L*i { Al gs9.19.911r911s.9#ilo g3lr. Of.tJl Jh?a+*.gtiT &li drQQ
:glr. sri





:ti,t jsr tl9to p;ru *LS
X.r,t"rt,-1
..l . 
^1r ., ;l^ ^" -(r-l6)'*.)y,6-r.
,-),G;f.: -Y
, P d.V.t.i+d i5l -f
$7(.A*-....... (:-r-' t-r) 0.,* q t uf M-yff;) 2t*1v/Y/.t 1r* :l
rJ, -r
.io, so*a dt
- 
/ , 
-J
